神経機器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の神経機器の市場規模は、2024年～2030年の予測期間にCAGRで7.46%の成長が見込まれます。市場は、世界中での神経機器の規制承認の増加などの要因により、楽観的な市場成長を示しています。さらに、事故や労働災害などによる頭部外傷の増加、老年人口の増加、神経疾患の有病率の増加などが、世界中でさまざまな神経機器の需要を増加させる見込みです。さらに、神経機器の安全性、入手性、エンドユーザーにとっての使いやすさの向上への注目の高まりにより、予測期間（2024年～2030年）に神経機器市場の大きな収益成長が見込まれています。

神経機器の市場力学

アルツハイマー病（AD）、ハンチントン病（HD）、パーキンソン病（PD）、多発性硬化症（MS）など、治療が困難な神経疾患の有病率の増加により、その治療と管理に向けた、より安全で効率的な薬剤分子の発見が求められています。世界保健機関（WHO）（2022）によると、2020年に全世界で約5,500万人が認知症に罹患し、毎年数百万人の認知症患者が発生しています。WHO（2022）によると、2019年に全世界で約850万人がパーキンソン病（PD）に罹患し、同資料によると、PDは580万の障害調整生存年をもたらしました。

老年人口の増加は、神経機器の成長におけるもう1つの大きな要因です。世界保健機関（WHO）（2022）によると、2030年までに少なくとも6人に1人が60歳以上になると予測されています。同資料によると、2050年までに60歳以上の人口は約21億人になります。年齢が上がるにつれて、認知症や脳卒中などのさまざまな神経疾患にかかる傾向が非常に強くなります。

したがって、上記の要因が総合的に2024年～2030年の予測期間に神経機器市場全体を牽引します。

しかし、さまざまな神経機器に関連する高いコストとリスクが、神経機器市場の成長抑制要因として作用する可能性があります。

神経機器市場は、COVID-19パンデミックの期間中、病院関係者や大衆への感染拡大のリスクを回避するためのロックダウンによりマイナスの影響を受けました。このため、病院や診療所の神経科が閉鎖され、COVID-19が世界中に拡大したため、神経手術が中断されました。さらに、市場におけるサプライチェーン、原材料、その他のリソースの不足により、すべての医療機器の製造が減少しました。しかし、COVID-19のワクチン開発により、ロックダウン規制が緩和され、経済情勢が正常化したことで、病院、診療所、研究所での治療や診断に向けた定期的な外来受診など、通常の医療サービスが再開されるようになり、神経機器市場における製品需要が軌道に乗りました。

神経機器市場のセグメント分析

神経機器市場の機器タイプセグメントでは、神経刺激療法セグメントが2023年に大きな収益シェアを占めると予測されています。これは主に、神経刺激機器に関連する主な利点によるものでした。

例えば、脊髄刺激機器などの神経刺激機器は、神経因性疼痛や脊髄損傷の治療に非常に効果的です。

これらの機器は、特定の深部皮質下、皮質、脊髄、頭蓋、末梢神経の構造を標的として、神経細胞活動を修正または調節するため、慢性疼痛、運動障害、てんかん、パーキンソン病など、数え切れないほどの神経疾患に治療効果をもたらします。

そのため、この製品タイプに対する需要の高まりを考慮し、数多くの新製品が市場に投入されています。例えば、2022年8月、Abbottは新しい脊髄刺激（SCS）システム、Proclaim（TM）Plusの米国食品医薬品局（FDA）の承認を取得しました。

2022年7月、NEVRO CORPは、有痛性糖尿病性神経障害（PDN）に伴う慢性疼痛治療用の10kHz高周波脊髄刺激療法が米国FDAの認可を取得したと発表しました。

このため、神経刺激機器に関連する利点と用途、市場での製品の発売の増加により、このカテゴリは予測期間にかなりの成長を示し、世界の神経機器市場全体の成長に寄与すると予測されます。

当レポートでは、世界の神経機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 神経機器市場レポートのイントロダクション

第2章 神経機器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 神経機器市場の主な要因の分析

• 神経機器市場の促進要因
  • 神経疾患の有病率の増加
  • 外傷の件数の増加
  • 低侵襲手術への需要の増加
• 神経機器市場の抑制要因と課題
  • これらの機器の高いコスト
  • 神経機器に関連するリスク
• 神経機器市場の機会
  • 新興市場全体への医療インフラの拡大
  • 研究開発活動の増加

第5章 神経機器市場のポーターのファイブフォース分析

第6章 神経機器市場に対するCOVID-19COVID-19の影響分析

第7章 神経機器市場のレイアウト

• 機器タイプ別
  • 神経刺激機器
  • 脳神経手術機器
  • 脳脊髄液管理機器
  • 神経インターベンション
  • その他
• 用途別
  • 診断
  • 治療
• エンドユーザー別
  • 病院
  • 専門クリニック
  • 外来手術センター
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 神経機器市場の企業と製品のプロファイル

• Abbott
• B. Braun SE
• Boston Scientific Corporation
• Integra LifeSciences
• LivaNova PLC
• Medtronic
• MagstimTMS
• Penumbra, Inc
• Stryker
• MicroPort Scientific Corporation
• Koninklijke Philips N.V.
• Rapid Medical
• Acandis GmbH
• Cerus Endovascular Inc.
• Helius Medical Technologies
• Zimmer Biomet
• Sense Neuro
• Natus Medical Incorporated.
• Braintale SAS
• Avanos Medical, Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Neurology Devices Market
• Table 3: Neurology Devices Market Analysis in Global (2021-2030)
• Table 4: Neurology Devices Market Analysis in Global by Device Type (2021-2030)
• Table 5: Neurology Devices Market Analysis in Global by Application (2021-2030)
• Table 6: Neurology Devices Market Analysis in Global by End-user (2021-2030)
• Table 7: Neurology Devices Market Analysis in Global by Geography (2021-2030)
• Table 8: Neurology Devices Market Analysis in North America (2021-2030)
• Table 9: Neurology Devices Market Analysis in North America by Country (2021-2030)
• Table 10: Neurology Devices Market Analysis in the US (2021-2030)
• Table 11: Neurology Devices Market Analysis in Canada (2021-2030)
• Table 12: Neurology Devices Market Analysis in Mexico (2021-2030)
• Table 13: Neurology Devices Market Analysis in Europe (2021-2030)
• Table 14: Neurology Devices Market Analysis in Europe by Country (2021-2030)
• Table 15: Neurology Devices Market Analysis in France (2021-2030)
• Table 16: Neurology Devices Market Analysis in Germany (2021-2030)
• Table 17: Neurology Devices Market Analysis in the UK (2021-2030)
• Table 18: Neurology Devices Market Analysis in Italy (2021-2030)
• Table 19: Neurology Devices Market Analysis in Spain (2021-2030)
• Table 20: Neurology Devices Market Analysis in the Rest of Europe (2021-2030)
• Table 21: Neurology Devices Market Analysis in Asia-Pacific (2021-2030)
• Table 22: Neurology Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 23: Neurology Devices Market Analysis in China (2021-2030)
• Table 24: Neurology Devices Market Analysis in Japan (2021-2030)
• Table 25: Neurology Devices Market Analysis in India (2021-2030)
• Table 26: Neurology Devices Market Analysis in Australia (2021-2030)
• Table 27: Neurology Devices Market Analysis in South Korea (2021-2030)
• Table 28: Neurology Devices Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Table 29: Neurology Devices Market Analysis in the Rest of the World (2021-2030)
• Table 30: Neurology Devices Market Analysis in the Rest of the World by Region (2021-2030)
• Table 31: Neurology Devices Market Analysis in the Middle East (2021-2030)
• Table 32: Neurology Devices Market Analysis in Africa (2021-2030)
• Table 33: Neurology Devices Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Neurology Devices Market
• Figure 3: Neurology Devices Market Analysis in Global (2021-2030)
• Figure 4: Neurology Devices Market Analysis in Global by Device Type (2021-2030)
• Figure 5: Neurology Devices Market Analysis in Global by Application (2021-2030)
• Figure 6: Neurology Devices Market Analysis in Global by End-user (2021-2030)
• Figure 7: Neurology Devices Market Analysis in Global by Geography (2021-2030)
• Figure 8: Neurology Devices Market Analysis in North America (2021-2030)
• Figure 9: Neurology Devices Market Analysis in North America by Country (2021-2030)
• Figure 10: Neurology Devices Market Analysis in the US (2021-2030)
• Figure 11: Neurology Devices Market Analysis in Canada (2021-2030)
• Figure 12: Neurology Devices Market Analysis in Mexico (2021-2030)
• Figure 13: Neurology Devices Market Analysis in Europe (2021-2030)
• Figure 14: Neurology Devices Market Analysis in Europe by Country (2021-2030)
• Figure 15: Neurology Devices Market Analysis in France (2021-2030)
• Figure 16: Neurology Devices Market Analysis in Germany (2021-2030)
• Figure 17: Neurology Devices Market Analysis in the UK (2021-2030)
• Figure 18: Neurology Devices Market Analysis in Italy (2021-2030)
• Figure 19: Neurology Devices Market Analysis in Spain (2021-2030)
• Figure 20: Neurology Devices Market Analysis in the Rest of Europe (2021-2030)
• Figure 21: Neurology Devices Market Analysis in Asia-Pacific (2021-2030)
• Figure 22: Neurology Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 23: Neurology Devices Market Analysis in China (2021-2030)
• Figure 24: Neurology Devices Market Analysis in Japan (2021-2030)
• Figure 25: Neurology Devices Market Analysis in India (2021-2030)
• Figure 26: Neurology Devices Market Analysis in Australia (2021-2030)
• Figure 27: Neurology Devices Market Analysis in South Korea (2021-2030)
• Figure 28: Neurology Devices Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Figure 29: Neurology Devices Market Analysis in the Rest of the World (2021-2030)
• Figure 30: Neurology Devices Market Analysis in the Rest of the World by Region (2021-2030)
• Figure 31: Neurology Devices Market Analysis in the Middle East (2021-2030)
• Figure 32: Neurology Devices Market Analysis in Africa (2021-2030)
• Figure 33: Neurology Devices Market Analysis in South America (2021-2030)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Market Opportunities
• Figure 37: PORTER's Five Force Analysis

Neurology Devices Market By Device Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, And Others ], By Application (Diagnosis And Treatment), By End-User (Hospitals, Speciality Clinics, And Ambulatory Surgical Centers), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence and incidence of brain injury, dementia, alzheimer's diseases, and others, and the rising burden of geriatric population across the globe

The global neurology devices market is estimated to grow at a CAGR of 7.46% during the forecast period from 2024 to 2030. The neurology devices market is observing optimistic market growth due to factors such as the rise in the number of regulatory approvals for neurology devices across the globe. Further, the increasing cases of head injuries owing to accidents, workplace injuries, and others, and the rise in the geriatric population coupled with the increasing prevalence of neurological diseases are going to increase the demand for various neurological devices across the globe. Additionally, the growing focus on improving the safety, affordability, and usability of neurology devices for end users is further expected to result in appreciable revenue growth in the neurology devices market during the forecast period (2024-2030).

Neurology Devices Market Dynamics:

The increasing prevalence of hard-to-treat neurological diseases such as Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), and multiple sclerosis (MS) among others will require the discovery of safer and more efficient drug molecules for their treatment and management. As per the World Health Organization (WHO) 2022, worldwide around 55 million people were suffering from dementia in 2020 and every year millions of cases of dementia take place. According to WHO 2022, worldwide around 8.5 million people had Parkinson's disease (PD) in 2019 and as per the same source, PD lead to 5.8 million disability-adjusted life years.

The increasing geriatric population is another major factor in the growth of neurology devices. As per the World Health Organization 2022, it is expected that by 2030, out of 6 at least 1 person will have his/her age 60 years or above. As per the same source, by 2050, the number of people aged 60 years or above will be around 2.1 billion. With increasing age, the tendency to suffer from various neurological diseases such as dementia, stroke, and others increases tremendously.

Therefore, the factors stated above collectively will drive the overall neurology devices market during the forecast period from 2024-2030.

However, the high cost and risk associated with various neurology devices may act as a restraint in the neurology devices market growth.

The Neurology Devices Market was negatively impacted during the period of COVID- 19 pandemic owing to the lockdown impositions to avoid the risk of the spread of the disease among hospital personnel and the general public. This led to the closure of neurology departments in hospitals and clinics leading to the suspension of neurological procedures due to the huge spread of COVID-19 infection across the globe. Further, shortage of supply chains, raw materials, and other resources in the market, leading to the decreased manufacturing of all medical devices. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has initiated the process of resumption of regular healthcare services such as regular out-patients visits for treatments and diagnosis in hospitals, clinics, and laboratories, thereby bringing the demand for products on track in the neurology devices market.

Neurology Devices Market Segment Analysis:

Neurology Devices Market By Product Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, and Others], By Application (Diagnosis and Treatment), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the Neurology Devices market, the neurostimulation segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the key benefits related to neurostimulation devices.

For instance, neurostimulation devices such as spinal cord stimulators are highly effective in treating neuropathic pain and spinal injuries.

These devices target specific deep subcortical, cortical, spinal, cranial, and peripheral nerve structures to modify or modulate neuronal activity and therefore provide therapeutic effects for countless neurological diseases including chronic pain, movement disorders, epilepsy, and Parkinson's disease among others.

Therefore, considering the growing demand for this product type, numerous new products are being launched in the market. For example, In August 2022, Abbott received U.S. Food and Drug Administration (FDA) approval for its new Proclaim(TM) Plus spinal cord stimulation (SCS) system.

In July 2022, NEVRO CORP announced that it has received US FDA clearance for its 10 kHz high-frequency spinal cord stimulation therapy for the treatment of chronic pain associated with painful diabetic neuropathy (PDN).

Therefore, owing to the advantages and applications associated with neurostimulation devices along with the increasing product launches in the market, the category is expected to witness considerable growth eventually contributing to the overall growth of the global neurology devices market during the forecast period.

North America is expected to dominate the overall Neurology Devices Market:

Among all the regions, North America is expected to dominate the global neurology devices in the year 2023 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the rising prevalence of head injuries and neurological diseases including Parkinson's disease, Alzheimer's disease, and others; the rise in the geriatric population, rising product launches and approvals in the region, the presence of key market players in the region, and others will increase the demand of neurology devices in the given forecast period.

For instance, according to the latest data available from the American Society for Biochemistry and Molecular Biology data published in the year 2023, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. Moreover, as per the above-referenced source and statistics, about 2.8 million people suffer from traumatic brain injury (TBI) each year in the United States from which 2,80,000 result in hospitalizations. Therefore, rising cases of head injuries such as Traumatic Brain Injury (TBI) will increase the demand for neurology devices.

Additionally, as per the latest information provided by Parkinson's Foundation, every year approximately 60,000 people in America are diagnosed with PD. Also, the data provided by GLOBOCAN 2020 says that around 24,538 cancer cases of the brain and central nervous system were recorded in the US in 2020.

Also, the increasing prevalence of Alzheimer's disease in the United States will drive the market for diagnostic devices. As per the data provided by the Alzheimer Association (2023), more than 6 million Americans are living with Alzheimer's. By 2050, this number is projected to rise to nearly 13 million. The increasing prevalence of Alzheimer's disease in the United States will increase the demand for its diagnostics devices, ultimately leading to increased overall market growth.

Therefore, the interplay of the above-mentioned factors would provide a conducive environment for the growth of the North America neurology devices market.

Neurology Devices Market Key Players:

Some of the key market players operating in the neurology devices market include Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.

Recent Developmental Activities in the Neurology Devices Market:

In May 2022, the US Food and Drug Administration today permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer's disease.

In November 2022, Insightec received US FDA approval for a new device intended for treating patients with advanced Parkinson's disease named Exablate Neuro.

In April 2020, Brainquant, a quantitative brain measurement device, launched by Braintale SAS received CE mark approval for managing patients in a coma following brain injury.

Key Takeaways from the Neurology Devices Market Report Study

• Market size analysis for current neurology devices market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurology Devices market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global neurology devices market.
• Various opportunities available for the other competitor in the Neurology Devices Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current Neurology Devices Market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Neurology Devices Market growth in the coming future?

Target Audience who can be benefited from this Neurology Devices Market Report Study

• Neurology Devices products providers
• Research organizations and consulting companies
• Neurology Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Neurology Devices
• Various end users who want to know more about the neurology devices market and the latest technological developments in the neurology devices market.

Frequently Asked Questions for the Neurology Devices Market:

1. What is a neurology device?

Neurological devices are medical devices that are meant for the diagnosis and treatment of several neurological diseases and include neurostimulation devices, neurosurgery devices, and others.

2. What is the global market for Neurology Devices?

The global neurology devices market is estimated to grow at a CAGR of 7.46% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Neurology Devices market?

The neurology devices market is witnessing positive market growth owing to the increasing prevalence and incidence of brain injury, dementia, Alzheimer's diseases, and others; the rising burden of the geriatric population across the globe, and others will create an exigency in the Neurology Devices market.

4. Who are the key players operating in the global Neurology Devices market?

Some of the key market players operating in the neurology devices market include Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.

5. Which region has the highest share in the Neurology Devices market?

Among all the regions, North America is estimated to amass a significant revenue share in the global neurology devices market. This can be ascribed to the rising prevalence of head injuries, Parkinson's disease, Alzheimer's disease, and others; the rise in the geriatric population and the presence of key market players in the region are factors that act as a supportive factors for the North America Neurology Devices Market growth.

Table of Contents

1.Neurology Devices Market Report Introduction

2.Neurology Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Neurology Devices Market Key Factors Analysis

• 4.1. Neurology Devices Market Drivers
  • 4.1.1. Increasing prevalence of neurological diseases
  • 4.1.2. Rising number of traumatic injuries
  • 4.1.3. Increasing demand for minimally invasive surgeries
• 4.2. Neurology Devices Market Restraints and Challenges
  • 4.2.1. High Cost of these devices
  • 4.2.2. The risk associated with neurology devices
• 4.3. Neurology Devices Market Opportunities
  • 4.3.1. Expansion of healthcare infrastructure across emerging markets
  • 4.3.2. Increasing research and development activities

5. Neurology Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Neurology DevicesMarket

7. Neurology Devices Market Layout

• 7.1. By Device Type
  • 7.1.1. Neurostimulation Devices
  • 7.1.2. Neurosurgery Devices
  • 7.1.3. Cerebrospinal Fluid Management Devices
  • 7.1.4. Interventional Neurology
  • 7.1.5. Others
• 7.2. By Application
  • 7.2.1. Diagnosis
  • 7.2.2. Treatment
• 7.2. By End-User
  • 7.2.1. Hospitals
  • 7.2.2. Specialty Clinics
  • 7.2.3. Ambulatory Surgical Centers
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Neurology Devices Market in USD million (2021-2030)
    • 7.3.1.2. Canada Neurology Devices Market in USD million (2021-2030)
    • 7.3.1.3. Mexico Neurology Devices Market in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Neurology Devices Market in USD million (2021-2030)
    • 7.3.2.2. Germany Neurology Devices Market in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Neurology Devices Market in USD million (2021-2030)
    • 7.3.2.4. Italy Neurology Devices Market in USD million (2021-2030)
    • 7.3.2.5. Spain Neurology Devices Market in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Neurology Devices Market in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Neurology Devices Market in USD million (2021-2030)
    • 7.3.3.2. Japan Neurology Devices Market in USD million (2021-2030)
    • 7.3.3.3. India Neurology Devices Market in USD million (2021-2030)
    • 7.3.3.4. Australia Neurology Devices Market in USD million (2021-2030)
    • 7.3.3.5. South Korea Neurology Devices Market in USD million (2021-2030)
    • 7.3.3.6. Rest of Asia Pacific Neurology Devices Market in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Neurology Devices Market in USD million (2021-2030)
    • 7.3.4.2. Africa Neurology Devices Market in USD million (2021-2030)
    • 7.3.4.3. South America Neurology Devices Market in USD million (2021-2030)

8. Neurology Devices Market Company and Product Profiles

• 8.1. Abbott
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. B. Braun SE
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Boston Scientific Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Integra LifeSciences
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. LivaNova PLC
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Medtronic
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. MagstimTMS
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Penumbra, Inc
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Stryker
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. MicroPort Scientific Corporation
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Koninklijke Philips N.V.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Rapid Medical
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Acandis GmbH
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Cerus Endovascular Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Helius Medical Technologies
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Zimmer Biomet
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Sense Neuro
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Natus Medical Incorporated.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Braintale SAS
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Avanos Medical, Inc.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us